BioTuesdays

Category - Developments

ADMA Biologics Logo

ADMA Biologics ASCENIV gets FDA approval

ADMA Biologics’ (NASDAQ:ADMA) ASCENIV has received FDA approval for the treatment of primary humoral immunodeficiency disease (PI) in adults and adolescents. The approval is based on results of a pivotal Phase 3...

Aphria Logo

Aphria launches CBD-based products in Germany

Aphria (TSX:APHA; NYSE:APHA) has launched CannRelief, a cannabidiol (CBD)-based nutraceutical and cosmetics line, through its subsidiary Aphria Deutschland. Featuring hemp-derived CBD, CannRelief products are produced...

Fluidigm

Fluidigm introduces new immune profiling system

Fluidigm’s (NASDAQ:FLDM) new immune profiling system, Maxpar Direct, quantifies immune cell populations with automated five-minute results reporting. Maxpar Direct uses a single-tube workflow to profile 37 different...